Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz175.744
Abstract: Epidermal growth factor receptor amplification (EGFRamp), occurs in >60% of Glioblastoma (GBM) patients, and can predict response to alkylating chemotherapy. However, due to high genetic instability in GBM, a significant caveat to sampling EGFRamp during…
read more here.
Keywords:
biopsy;
radiomic features;
amp;
non amp ... See more keywords